Preoperative Inflammation-Associated Blood Cell Markers in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Study

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166
   PubMed Web of Science ®Google Scholar
• Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54(1):8–29. doi:10.3322/canjclin.54.1.8
   PubMed Web of Science ®Google Scholar
• Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105. doi:10.1016/j.eururo.2016.02.029
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. doi:10.1016/j.eururo.2019.02.011
   PubMed Web of Science ®Google Scholar
• Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349(nov10 11):g4797. doi:10.1136/bmj.g4797
   PubMed Web of Science ®Google Scholar
• Stewart SB, Thompson RH, Psutka SP, et al. Evaluation of the national comprehensive cancer network and American Urological Association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014;32(36):4059–4065. doi:10.1200/JCO.2014.56.5416
   PubMed Web of Science ®Google Scholar
• Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002;20(23):4559–4566. doi:10.1200/JCO.2002.05.111
   PubMed Web of Science ®Google Scholar
• Patard -J-J, Kim HL, Lam JS, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004;22(16):3316–3322. doi:10.1200/JCO.2004.09.104
   PubMed Web of Science ®Google Scholar
• Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002;168(6):2395–2400. doi:10.1016/S0022-5347(05)64153-5
   PubMed Web of Science ®Google Scholar
• Ficarra V, Martignoni G, Lohse C, et al. External validation of the mayo clinic stage, size, grade and necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol. 2006;175(4):1235–1239. doi:10.1016/S0022-5347(05)00684-1
   PubMed Web of Science ®Google Scholar
• Shuch BM, Lam JS, Belldegrun AS, et al. Prognostic factors in renal cell carcinoma. Semin Oncol. 2006;33(5):563–575. doi:10.1053/j.seminoncol.2006.06.006
   PubMed Web of Science ®Google Scholar
• Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35(2):261–270. doi:10.1007/s00345-016-1864-9
   PubMed Web of Science ®Google Scholar
• de Martino M, Pantuck AJ, Hofbauer S, et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190(6):1999–2004. doi:10.1016/j.juro.2013.06.082
   PubMed Web of Science ®Google Scholar
• Hutterer GC, Stoeckigt C, Stojakovic T, et al. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. Urol Oncol. 2014;32(7):1041–1048. doi:10.1016/j.urolonc.2014.04.001
   PubMed Web of Science ®Google Scholar
• Keizman D, Ish-Shalom M, Huang P, et al. The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer. 2012;48(2):202–208. doi:10.1016/j.ejca.2011.09.001
   PubMed Web of Science ®Google Scholar
• Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol. 2006;24(13):1997–2005. doi:10.1200/JCO.2005.03.9594
   PubMed Web of Science ®Google Scholar
• Atzpodien J, Royston P, Wandert T, et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003;88(3):348–353. doi:10.1038/sj.bjc.6600768
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6(7):1235–1239. doi:10.1097/00000478-198210000-00007
   Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546. doi:10.1001/jama.1982.03320430047030
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju124
   PubMedGoogle Scholar
• Ohno Y, Nakashima J, Ohori M, et al. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol. 2010;184(3):1041–1048. doi:10.1016/j.juro.2010.05.028
   Web of Science ®Google Scholar
• Kim TW, Lee JH, Shim KH, et al. Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. Invest Clin Urol. 2019;60(1):14–20. doi:10.4111/icu.2019.60.1.14
   PubMed Web of Science ®Google Scholar
• Lee A, Lee HJ, Huang HH, et al. Prognostic significance of inflammation-associated blood cell markers in nonmetastatic clear cell renal cell carcinoma. Clin Genitourin Cancer. 2020;18(4):304–313. doi:10.1016/j.clgc.2019.11.013
   PubMed Web of Science ®Google Scholar
• Attawettayanon W, Choorit T, Chalieopanyarwong V, et al. Significance of preoperative hematologic scoring in predicting death among patients with non-metastatic renal cell carcinoma undergoing nephrectomy. Asian J Surg. 2021;44(7):952–956. doi:10.1016/j.asjsur.2021.01.029
   PubMed Web of Science ®Google Scholar
• Soehnlein O. An elegant defense: how neutrophils shape the immune response. Trends Immunol. 2009;30(11):511–512. doi:10.1016/j.it.2009.07.002
   PubMed Web of Science ®Google Scholar
• Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A. 2006;103(33):12493–12498. doi:10.1073/pnas.0601807103
   PubMed Web of Science ®Google Scholar
• Gooden MJ, de Bock GH, Leffers N, et al. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105(1):93–103. doi:10.1038/bjc.2011.189
   PubMed Web of Science ®Google Scholar
• Forhecz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659–666. doi:10.1016/j.ahj.2009.07.024
   PubMed Web of Science ®Google Scholar
• Montagnana M, Danese E. Red cell distribution width and cancer. Ann Transl Med. 2016;4(20):399. doi:10.21037/atm.2016.10.50
   PubMed Web of Science ®Google Scholar
• Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628–632. doi:10.5858/133.4.628
   PubMed Web of Science ®Google Scholar
• Zyczkowski M, Rajwa P, Gabrys E, et al. The relationship between red cell distribution width and cancer-specific survival in patients with renal cell carcinoma treated with partial and radical nephrectomy. Clin Genitourin Cancer. 2018;16(3):e677–e683. doi:10.1016/j.clgc.2017.12.003
   PubMed Web of Science ®Google Scholar